慢性阻塞性肺疾病急性加重。4：预防。
COPD exacerbations. 4: Prevention.
作者信息
Scott S, Walker P, Calverley P M A
机构信息
Division of Infection and Immunity, Clinical Sciences Centre, University Hospital Aintree, Liverpool L9 7AL, UK.
出版信息
Thorax. 2006 May;61(5):440-7. doi: 10.1136/thx.2005.041848.
Abstract
A review of the evidence that the prevention of COPD works and, if so, the effectiveness of this strategy
摘要
关于慢性阻塞性肺疾病（COPD）预防措施是否有效的证据综述，若有效，则对该策略的有效性进行综述
相似文献
1
COPD exacerbations. 4: Prevention.慢性阻塞性肺疾病急性加重。4：预防。
Thorax. 2006 May;61(5):440-7. doi: 10.1136/thx.2005.041848.
2
Interventions to prevent chronic obstructive pulmonary disease exacerbations.预防慢性阻塞性肺疾病急性加重的干预措施。
Am J Med. 2004 Dec 20;117 Suppl 12A(12):41S-48S. doi: 10.1016/j.amjmed.2004.10.021.
3
ABC of chronic obstructive pulmonary disease. Acute exacerbations.慢性阻塞性肺疾病基础。急性加重
BMJ. 2006 Jul 8;333(7558):87-9. doi: 10.1136/bmj.333.7558.87.
4
[Etiological and exacerbation factors for COPD. Respiratory tract infections].[慢性阻塞性肺疾病的病因及加重因素。呼吸道感染]
Nihon Rinsho. 2016 May;74(5):747-51.
5
[Prevention of COPD exacerbations: conducting a clinical trial evaluating the benefits of inhaled steroids].慢性阻塞性肺疾病（COPD）急性加重的预防：开展一项评估吸入性糖皮质激素益处的临床试验
Rev Mal Respir. 2004 Sep;21(4 Pt 1):685-8. doi: 10.1016/s0761-8425(04)71408-4.
6
COPD exacerbations: causes, prevention, and treatment.慢性阻塞性肺疾病加重：病因、预防和治疗。
Med Clin North Am. 2012 Jul;96(4):789-809. doi: 10.1016/j.mcna.2012.02.008. Epub 2012 Mar 16.
7
[Prevention of chronic obstructive pulmonary disease exacerbations].[慢性阻塞性肺疾病急性加重的预防]
Presse Med. 2008 Nov;37(11):1604-8. doi: 10.1016/j.lpm.2008.08.003. Epub 2008 Sep 30.
8
Initial periodontal treatment for prevention of chronic obstructive pulmonary disease exacerbations.牙周基础治疗预防慢性阻塞性肺疾病急性加重。
J Periodontol. 2013 Jul;84(7):863-70. doi: 10.1902/jop.2012.120399. Epub 2012 Sep 24.
9
State of the Art Compendium: Canadian Thoracic Society recommendations for the management of chronic obstructive pulmonary disease.最新技术纲要：加拿大胸科学会慢性阻塞性肺疾病管理指南
Can Respir J. 2004 Jul-Aug;11 Suppl B:7B-59B. doi: 10.1155/2004/946769.
10
Noninvasive ventilation with helium-oxygen rather than air-oxygen in acute exacerbations of chronic obstructive disease?在慢性阻塞性肺疾病急性加重期使用氦氧而非空气氧进行无创通气？
Crit Care Med. 2003 Mar;31(3):990-1. doi: 10.1097/01.CCM.0000055368.57291.06.
引用本文的文献
1
Chronic obstructive pulmonary disease in China: the potential role of indacaterol.中国的慢性阻塞性肺疾病：茚达特罗的潜在作用。
J Thorac Dis. 2013 Aug;5(4):549-58. doi: 10.3978/j.issn.2072-1439.2013.08.04.
2
Inhaled corticosteroids for stable chronic obstructive pulmonary disease.吸入性糖皮质激素用于稳定期慢性阻塞性肺疾病
Cochrane Database Syst Rev. 2012 Jul 11;2012(7):CD002991. doi: 10.1002/14651858.CD002991.pub3.
3
COPD: what is the unmet need?慢性阻塞性肺疾病：未满足的需求是什么？
Br J Pharmacol. 2008 Oct;155(4):487-93. doi: 10.1038/bjp.2008.362. Epub 2008 Sep 15.
4
COPD exacerbations: defining their cause and prevention.慢性阻塞性肺疾病急性加重：明确其病因与预防措施
Lancet. 2007 Sep 1;370(9589):786-96. doi: 10.1016/S0140-6736(07)61382-8.
5
Management of acute exacerbations of chronic obstructive pulmonary disease in the elderly : an appraisal of published evidence.老年人慢性阻塞性肺疾病急性加重的管理：已发表证据的评估
Drugs Aging. 2007;24(4):303-24. doi: 10.2165/00002512-200724040-00004.
6
Viral-associated exacerbations of asthma and COPD.病毒相关的哮喘和慢性阻塞性肺疾病加重
Curr Opin Pharmacol. 2007 Jun;7(3):252-8. doi: 10.1016/j.coph.2006.11.010. Epub 2007 Mar 21.
7
The burden of lung disease.肺部疾病的负担。
Thorax. 2006 Jul;61(7):557-8. doi: 10.1136/thx.2006.066050.
本文引用的文献
1
Lung mechanics and dyspnea during exacerbations of chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重期的肺力学与呼吸困难
Am J Respir Crit Care Med. 2005 Dec 15;172(12):1510-6. doi: 10.1164/rccm.200504-595OC. Epub 2005 Sep 15.
2
Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trial.噻托溴铵（一种每日一次吸入用抗胆碱能支气管扩张剂）预防慢性阻塞性肺疾病急性加重的随机试验。
Ann Intern Med. 2005 Sep 6;143(5):317-26. doi: 10.7326/0003-4819-143-5-200509060-00007.
3
Physiological changes during symptom recovery from moderate exacerbations of COPD.慢性阻塞性肺疾病中度加重症状恢复期间的生理变化。
Eur Respir J. 2005 Sep;26(3):420-8. doi: 10.1183/09031936.05.00136304.
4
Relationship between respiratory symptoms and medical treatment in exacerbations of COPD.慢性阻塞性肺疾病急性加重期呼吸症状与药物治疗之间的关系
Eur Respir J. 2005 Sep;26(3):406-13. doi: 10.1183/09031936.05.00143404.
5
Roflumilast--an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial.罗氟司特——一种用于慢性阻塞性肺疾病的口服抗炎治疗药物：一项随机对照试验。
Lancet. 2005;366(9485):563-71. doi: 10.1016/S0140-6736(05)67100-0.
6
Effect of salbutamol on lung function and chest wall volumes at rest and during exercise in COPD.沙丁胺醇对慢性阻塞性肺疾病（COPD）患者静息及运动时肺功能和胸壁容积的影响。
Thorax. 2005 Nov;60(11):916-24. doi: 10.1136/thx.2004.037937. Epub 2005 Jun 30.
7
Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial.慢性阻塞性肺疾病（COPD）患者从沙美特罗/丙酸氟替卡松联合治疗中撤用丙酸氟替卡松会导致疾病立即且持续恶化：一项随机对照试验
Thorax. 2005 Jun;60(6):480-7. doi: 10.1136/thx.2004.034280.
8
Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial.N-乙酰半胱氨酸对慢性阻塞性肺疾病预后的影响（N-乙酰半胱氨酸成本-效用研究中的支气管炎随机试验，BRONCUS）：一项随机安慰剂对照试验
Lancet. 2005;365(9470):1552-60. doi: 10.1016/S0140-6736(05)66456-2.
9
Treatment with the immunomodulator AM3 improves the health-related quality of life of patients with COPD.使用免疫调节剂AM3进行治疗可改善慢性阻塞性肺疾病（COPD）患者与健康相关的生活质量。
Chest. 2005 Apr;127(4):1212-8. doi: 10.1378/chest.127.4.1212.
10
Epidemiological differences among pneumococcal serotypes.肺炎球菌血清型之间的流行病学差异。
Lancet Infect Dis. 2005 Feb;5(2):83-93. doi: 10.1016/S1473-3099(05)01280-6.
Zotero 插件